Lymphocyte count – Communicable Diseases Research

Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients

Article

Published on 2022-11-012022-11-15
Journal: Clinical gastroenterology and hepatology : the off
[Category] COVID19(2023년), SARS, 진단, 치료기술,

The effect of Nutrition Bio-shield superfood (NBS) on disease severity and laboratory biomarkers in patients with COVID-19: A randomized clinical trial

Article

Published on 2022-11-012022-11-15
Journal: Microbial pathogenesis
[Category] SARS, 바이오마커,

[키워드] ALP assigned baseline body temperature can be used clinical clinical trial Clinical trial study control group COVID-19 COVID-19 disease COVID-19 disease severity CPK CRP determine dimer disease severity Effect effective ELISA kit ESR IL-6 immune system IMPROVE Intervention intervention group Iran laboratory biomarker laboratory biomarkers laboratory parameter LDH lymphocyte Lymphocyte count nutrition Nutrition bio-shield superfood. oxygen saturation Patient patients with COVID-19 performed Placebo Randomized randomized clinical trial receiving Result Serum level serum sample SGOT SGPT significant decrease significant increase single-blind Superfood Tehran tested the mean TNF-α Treatment Trial two group Two-arm variable was performed WBC
[DOI] 10.1016/j.micpath.2022.105792 PMC 바로가기

Serological biomarkers of COVID-19 severity at hospital admission are not related to long-term post-COVID pain symptoms in hospitalized COVID-19 survivors

Article

Published on 2022-11-012022-11-15
Journal: Pain
[Category] COVID19(2023년), SARS, 바이오마커,

Humoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes

Article

Published on 2022-11-012022-10-05
Journal: Multiple sclerosis and related disorders
[Category] COVID19(2023년), SARS, 바이오마커, 진단, 치료기술,

[키워드] administration age anti-CD20 anti-CD20 therapy Anti-SARS-CoV-2 S antibody Antibody Response Antibody titer appear B-cell CD20 cell count Clinical outcome Cohort collected Comprehensive COVID-19 COVID-19 infection COVID-19 vaccination death demographic demonstrated diagnosed with COVID-19 died disease Disease modifying therapy effective enrolled female FIVE Follow-up healthy control healthy controls humoral Humoral immunity Humoral response ICU care Immune profile immunoglobulins incidence increased risk investigation less longitudinal Lymphocyte count Multiple multiple sclerosis outcome Patient preventing infection profile reduced required Responder response to vaccination Result retrospective SARS-CoV-2 spike sclerosis serum severe disease significantly lower single-center study therapy Treatment vaccinated against COVID-19 vaccination Vaccine
[DOI] 10.1016/j.msard.2022.104079 [Article Type] Article

[Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China]

Article

Published on 2022-10-152022-11-16
Journal: Zhongguo dang dai er ke za zhi = Chinese journal o
[Category] COVID19(2023년), SARS, 변종,

[키워드] abnormality accounted acute respiratory syndrome age alanine aminotransferase Aspartate aminotransferase Care Chest CT Child children Chinese clinical clinical feature close contact Cluster common clinical symptom coronavirus coronavirus disease cough COVID-19 creatinine cured diagnosed discharged English Epidemic feature Fever Infant infected with SARS-CoV-2 Infection interferon involved Liver function Lymphocyte count median age Mild Mild symptom MOST omicron Omicron variant outbreak parameter Platelet Pneumonia procalcitonin Prognosis ranged renal function SARS-CoV-2 SARS-CoV-2 vaccine Severe acute respiratory syndrome coronavirus 2 infection. Severe case strain Symptomatic treatment underlying diseases urea variant were given White blood cell
[DOI] 10.7499/j.issn.1008-8830.2205122 PMC 바로가기

Characterization of coagulopathy and outcomes in cancer patients with severe COVID -19 illness: Longitudinal changes in hospitalized cancer patients

Article

Published on 2022-10-012022-11-15
Journal: Cancer Medicine
[Category] COVID19(2023년), SARS, 바이오마커,

[키워드] 1:1 Anderson blood cell count Cancer cancer patient Cancer patients CBC center change changes in characterization clinical clinical observations Coagulopathy Complete correlated COVID COVID-19 COVID-19 illness COVID-19 patient Critical CRP death disease elevated feature fibrinogen FIVE future risk had more help hematological hematological cancer Hospital admission Hospital stay Hospitalization Hospitalized IL-6 inflammatory markers interleukin-6 lack longitudinal Lymphocyte count management measure mechanical ventilation mechanism Mortality neutrophil Non-COVID-19 outcome outcomes Peripheral blood Platelet prognostic Prognostic factor required Retrospective analysis risk Risk assessment Serum ferritin severe COVID-19 illness Stratification survival thrombosis Thrombotic complications unique viral infection Viral infection. with COVID-19
[DOI] 10.1002/cam4.4753 PMC 바로가기

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK

Article

Published on 2022-09-292022-11-15
Journal: Clinical and experimental immunology
[Category] SARS, 진단,

Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4+/CD8+ cells in COVID-19 patients

Article

Published on 2022-09-232022-11-15
Journal: Medicine
[Category] 바이오마커, 치료제,

[키워드] addition analyzed Apoptosis apoptotic apoptotic cell association blood cell C-reactive protein can be used CD4+ cell CD8+ cell Cell cell count cells characterized Chest CT Clinical severity confirmed case correlated correlation COVID-19 COVID-19 case COVID-19 patient COVID-19 patients CRP CTLA-4 cytotoxic T-lymphocyte antigen-4 detect Diagnosis diagnostic Dyspnea eosinophil expressing expression ferritin flow cytometry healthy control healthy volunteer In-patients Increased Infectious disease lymphocyte Lymphocyte count lymphopenia neutrophil Patient patients Platelet proportion reduced severity significant difference significantly therapeutic targets Total up-regulated WBCs while white with COVID-19
[DOI] 10.1097/MD.0000000000030650 PMC 바로가기

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines

Article

Published on 2022-09-142022-11-15
Journal: Frontiers in Immunology
[Category] SARS, 진단,

[키워드] anti-RBD antibody CD19 CD19+ CD3+ CD3+ CD19+ cell CD4+ cell CD4+ T cell Cell cells cellular immunity Clinical characteristics Concentration CXCL10 DNT effector memory enrolled groups humoral immune profiling immune response immune system immunogenicity immunotype inactivated Inactivated vaccine innate immune response liver liver transplant recipient Lymphocyte count monocyte NAb National Neutralizing Neutralizing antibodies neutralizing antibodies. neutralizing antibody plasma Population positive proportion provided recipient recipients reported responders responses SARS-CoV-2 SARS-CoV-2 inactivated vaccines severe adverse event single-cell T-cell three groups time TNF-alpha Type vaccination vaccination schedule were recorded
[DOI] 10.3389/fimmu.2022.954177 PMC 바로가기

Different clinical features of children and adults in regional outbreak of Delta COVID-19

Article

Published on 2022-09-082022-11-16
Journal: BMC Infectious Diseases
[Category] SARS, 변종,